Home > Insider Trading > Filing (0001651308-25-000105)

Filing Details

Accession Number:: 0001651308-25-000105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-12 17:39:37
Reporting Period:: 2025-06-10

Filing Date:: 2025-06-12
Accepted Time:: 2025-06-12 17:39:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651308	Beone Medicines Ltd.	ONC	Pharmaceutical Preparations (2834)	981209416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1662982	Xiaodong Wang	C/O Beone Medicines I Gmbh Aeschengraben 27, 21St Floor Basel V8 4051		Yes	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2025-06-10	98,696	$0.00	5,180,861	No	4	A	Direct
American Depositary Shares	Acquisiton	2025-06-10	41,760	$6.50	41,760	No	4	M	Direct
American Depositary Shares	Disposition	2025-06-10	2,901	$261.20	38,859	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-10	15,878	$262.20	22,981	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-10	16,094	$263.17	6,887	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-10	6,787	$264.08	100	No	4	S	Direct
American Depositary Shares	Disposition	2025-06-10	100	$264.85	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Share Option (Right to Buy)	Acquisiton	2025-06-10	185,796	$0.00	185,796	$20.26
Ordinary Shares	Share Option (Right to Buy)	Disposition	2025-06-10	542,880	$0.00	542,880	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
185,796		2035-06-09	No	4	A	Direct
7		2025-07-19	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	1,025,063	Indirect	See Footnote
Ordinary Shares	3,953,100	Indirect	See Footnote
Ordinary Shares	50	Indirect	See Footnote

Footnotes

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
These securities are held by the spouse of the Reporting Person.
Each American Depositary Share represents 13 Ordinary Shares.
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.66 to $261.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.66 to $262.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.66 to $263.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.66 to $264.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subjectto continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service.